HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Web of Science (1) Citing Articles via Google Scholar Google Scholar Articles by ZOR, U. Articles by SULMAN, F. G. Search for Related Content PubMed PubMed Citation Articles by ZOR, U. Articles by SULMAN, F. G.

It has been shown previously (Zor, Dikstein & Sulman, 1965a, b) that the monoamine oxidase inhibitor mebanazine inhibits the release of somatotrophin (STH). This could be demonstrated in rats by the marked decrease in the width of the epiphysial cartilage and by showing that the release of corticotrophin (ACTH), the natural antagonist of STH, was stimulated. This effect is greatly potentiated by corticosteroids.

The aim of the present study was to investigate to which of the enzyme systems involved in growth the ability of mebanazine to inhibit growth is related.

Immature male rats of the 'Sabra' strain of the Hebrew University, 5 weeks old, weighing 60 ± 5 g., received i.p. injections of mebanazine resinate (which contains only 35% of the base), 30 mg./kg./24 hr., for 20 days (six injections weekly). They were killed on the day after the last injection.

DNA was separated from RNA by the method